TY - JOUR
T1 - The role of human achaete-scute homolog-1 in medullary thyroid cancer cells
AU - Sippel, Rebecca S.
AU - Carpenter, Jennifer E.
AU - Kunnimalaiyaan, Muthusamy
AU - Chen, Herbert
AU - Nwariaku, Fiemu
AU - Carling, Tobias
AU - Olson, John E.
AU - Zeiger, Martha A.
PY - 2003/12
Y1 - 2003/12
N2 - Background. Human achaete-scute homolog-1 (hASH1) is a transcription factor that is expressed highly in neuroendocrine tumors such as medullary thyroid cancer (MTC). Thyroid C-cells do not develop in hASH1 knockout mice, which suggests that hASH1 is essential for normal C-cell development. Methods. To determine the effect of raf-1 induction on hASH1 and hormone production, we used an estrogen inducible raf-1 construct in MTC cell line (TT) cells (TT-raf cells). TT or TT-raf cells were treated with control or 1 μM estradiol. After 48 hours, the cells were analyzed for levels of hASH1 and chromogranin A by Western blotting and for calcitonin production by enzyme-linked immunosorbent assay. Results. Activation of raf-1 in the TT-raf cells resulted in high levels of phosphorylated MEK and ERK1/2, a morphologic transdifferentiation, and a decrease in chromogranin A and calcitonin levels that are associated with a reduction in hASH1 production. Furthermore, using MEK inhibitors, we demonstrated that these raf-1-mediated changes are dependent on MEK but not ERK1/2 activation. Conclusion. hASH1 down-regulation by raf-1 in MTC cells is associated with a significant decrease in hormone production. Thus, hASH1 appears to be important in the endocrine phenotype of MTC tumors and may serve as a molecular target for the treatment of patients with MTC.
AB - Background. Human achaete-scute homolog-1 (hASH1) is a transcription factor that is expressed highly in neuroendocrine tumors such as medullary thyroid cancer (MTC). Thyroid C-cells do not develop in hASH1 knockout mice, which suggests that hASH1 is essential for normal C-cell development. Methods. To determine the effect of raf-1 induction on hASH1 and hormone production, we used an estrogen inducible raf-1 construct in MTC cell line (TT) cells (TT-raf cells). TT or TT-raf cells were treated with control or 1 μM estradiol. After 48 hours, the cells were analyzed for levels of hASH1 and chromogranin A by Western blotting and for calcitonin production by enzyme-linked immunosorbent assay. Results. Activation of raf-1 in the TT-raf cells resulted in high levels of phosphorylated MEK and ERK1/2, a morphologic transdifferentiation, and a decrease in chromogranin A and calcitonin levels that are associated with a reduction in hASH1 production. Furthermore, using MEK inhibitors, we demonstrated that these raf-1-mediated changes are dependent on MEK but not ERK1/2 activation. Conclusion. hASH1 down-regulation by raf-1 in MTC cells is associated with a significant decrease in hormone production. Thus, hASH1 appears to be important in the endocrine phenotype of MTC tumors and may serve as a molecular target for the treatment of patients with MTC.
UR - http://www.scopus.com/inward/record.url?scp=0346887056&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0346887056&partnerID=8YFLogxK
U2 - 10.1016/S0039-6060(03)00418-5
DO - 10.1016/S0039-6060(03)00418-5
M3 - Article
C2 - 14668716
AN - SCOPUS:0346887056
SN - 0039-6060
VL - 134
SP - 866
EP - 871
JO - Surgery
JF - Surgery
IS - 6
ER -